Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
14.64 USD | +3.24% | -0.41% | -9.42% |
Kurzporträt
Mitarbeiterzahl: 355
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100,0
%
| 126 | 100,0 % | 159 | 100,0 % | +26.75% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
76,4
%
| 97 | 77,5 % | 122 | 76,4 % | +25.03% |
Rest of World
12,3
%
| 14 | 11,1 % | 20 | 12,3 % | +39.91% |
Germany
11,3
%
| 14 | 11,4 % | 18 | 11,3 % | +25.58% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17.05.18 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 01.02.15 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.23 |
Chief Tech/Sci/R&D Officer | - | 01.01.17 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 63 | 05.09.23 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 02.10.19 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 01.01.22 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 16.06.22 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 01.01.15 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18.09.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 01.09.16 |
Edward Benz
BRD | Director/Board Member | 78 | 01.07.19 |
Ron Squarer
CHM | Chairman | 57 | 04.12.19 |
John R. Martin
BRD | Director/Board Member | 63 | 01.02.15 |
James Bristol
BRD | Director/Board Member | 77 | 01.08.07 |
Susan Kelley
BRD | Director/Board Member | 69 | 08.07.19 |
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17.05.18 |
Dennis Walsh
BRD | Director/Board Member | 56 | 01.02.15 |
Director/Board Member | 66 | 01.11.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 80 800 062 | 56 163 557 ( 69,51 %) | 0 | 69,51 % |
Unternehmenskontakt
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-9.42% | 1.17 Mrd. | |
-2.11% | 103 Mrd. | |
+0.82% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.15% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-14.93% | 15.52 Mrd. | |
+3.43% | 13.86 Mrd. | |
+34.27% | 12.04 Mrd. |
- Börse
- Aktien
- A2H48H Aktie
- Unternehmen Deciphera Pharmaceuticals, Inc.